These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16700419)

  • 21. Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.
    Montazeri AH; Erskine JG; McQuaker IG
    Eur J Haematol; 2007 Jul; 79(1):69-71. PubMed ID: 17598839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L; Masood F
    J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteonecrosis of the jaw due to bisphosphonates.
    Prescrire Int; 2008 Oct; 17(97):202-3. PubMed ID: 19536938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
    Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
    J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
    [No Abstract]   [Full Text] [Related]  

  • 26. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
    Delibasi T; Altundag K; Kanlioglu Y
    J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
    [No Abstract]   [Full Text] [Related]  

  • 27. Bisphosphonates and oral pathology II. Osteonecrosis of the jaws: review of the literature before 2005.
    Estefanía Fresco R; Ponte Fernández R; Aguirre Urizar JM
    Med Oral Patol Oral Cir Bucal; 2006 Nov; 11(6):E456-61. PubMed ID: 17072246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survey of members of myeloma UK on biphosphonates-associated jaw osteonecrosis.
    Barker K; Lowe D; Olujohungbe A; Low E; Rogers SN
    Br J Haematol; 2007 Nov; 139(4):626-8. PubMed ID: 17922879
    [No Abstract]   [Full Text] [Related]  

  • 29. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE; Umland EM
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bisphosphonate-associated osteonecrosis of the jaws. 2. Six case reports].
    Kicken M; Van Cann EM; Koole R
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):428-31. PubMed ID: 17972611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonate related osteonecrosis of the jaws.
    Shah SA; Aslam A; Mirza AI; Ali S
    J Ayub Med Coll Abbottabad; 2010; 22(3):214-7. PubMed ID: 22338459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.
    Chaudhry AN; Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2007 May; 19(2):199-206, vi. PubMed ID: 18088878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
    Dimopoulos MA; Kastritis E; Anagnostopoulos A; Melakopoulos I; Gika D; Moulopoulos LA; Bamia C; Terpos E; Tsionos K; Bamias A
    Haematologica; 2006 Jul; 91(7):968-71. PubMed ID: 16757414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells.
    Allegra A; Oteri G; Nastro E; Alonci A; Bellomo G; Del Fabro V; Quartarone E; Alati C; De Ponte FS; Cicciù D; Musolino C
    Hematol Oncol; 2007 Dec; 25(4):164-9. PubMed ID: 17577204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between osteonecrosis of the jaws and chronic high-dosage intravenous bisphosphonates therapy.
    Graziani F; Cei S; La Ferla F; Cerri E; Itro A; Gabriele M
    J Craniofac Surg; 2006 Sep; 17(5):876-9. PubMed ID: 17003614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bisphosphonate-associated osteonecrosis of the jaws 1].
    Allard RH; Lips P; Eekhoff EM; van Merkesteyn JP; van der Waal I
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):423-7. PubMed ID: 17972610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteonecrosis of the jaw and bisphosphonates.
    Durie BG; Katz M; Crowley J
    N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16000365
    [No Abstract]   [Full Text] [Related]  

  • 40. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
    Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
    Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.